Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Biotechnology Industry — April 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.0:1
Daily Buy & Sell Volume
Apr 2, 2026
Purchase
Shares
713,800
Price
$2.10
Total Value
$1.50M
Shares Held After
3,288,539
% of Holdings
21.7%

Lipocine Inc. (LPCN)

Patel Mahesh V. — Director
Apr 2, 2026
Purchase
Shares
25,000
Price
$2.02
Total Value
$50.50K
Shares Held After
135,679
% of Holdings
18.4%

Neuraxis, INC (NRXS)

Henrichs Timothy Robert — Chief Financial Officer
Apr 1, 2026
Purchase
Shares
7,593
Price
$1.96
Total Value
$14.88K
Shares Held After
7,593
% of Holdings
100.0%

Neuraxis, INC (NRXS)

Carrico Thomas Joeseph — CRO, CCO, CPO
Apr 1, 2026
Purchase
Shares
667
Price
$1.96
Total Value
$1.31K
Shares Held After
331,903
% of Holdings
0.2%
Apr 1, 2026
Purchase
Shares
8,060
Price
$1.96
Total Value
$15.80K
Shares Held After
348,178
% of Holdings
2.3%
Apr 1, 2026
Purchase
Shares
15,000
Price
$3.14
Total Value
$47.10K
Shares Held After
47,500
% of Holdings
31.6%

Altimmune, Inc. (ALT)

WEAVER GREGORY L — Chief Financial Officer
Apr 1, 2026
Purchase
Shares
10,000
Price
$3.15
Total Value
$31.50K
Shares Held After
38,078
% of Holdings
26.3%
Version: v26.3.33